NIDA T32 Postdoctoral Fellowship in Addiction Research
The University of Texas Health Science Center at San Antonio is seeking qualified, highly motivated applicants for a NIDA T32 Postdoctoral Training Program. Postdoctoral fellows receive interdisciplinary training across various laboratories and areas of expertise, taking advantage of the research diversity of participating faculty mentors, including molecular pharmacology, electrophysiology, neurochemistry, biochemistry, neuropharmacology, behavioral pharmacology, clinical trials, and human laboratory studies.
- Initial 1-year appointment, renewable for up to 3 years
- Research training with outstanding, well-funded investigators
- Career development opportunities including “Getting a Job Boot Camp”
- Fringe benefits including health care
- Large trainee community and support from the UT Health Office of Postdoctoral Affairs
- Additional activities include:
- Journal clubs
- Opportunities to present at local (BBC) and national meetings
- Grant writing/reviewing workshops
- Career development workshops
- Community outreach activities
Eligibility: Applicants must possess a doctoral degree or equivalent and be a US Citizen, non-citizen national, or permanent resident of the US.
Application: Send curriculum vitae, letter of intent, and two letters of recommendation to firstname.lastname@example.org (Charles P France, PhD, Program Director, Department of Pharmacology, University of Texas Health Science Center, 7703 Floyd Curl Drive, Mail Code 7764, San Antonio, TX 78229). For more information, please visit the NIDA T32 Training Program Website (http://uthscsa.edu/ARTT/T32/index.asp).
The University of Texas Health Science Center at San Antonio is an Equal Opportunity/Affirmative Action Employer, including protected veterans and persons with disabilities. All Postdoctoral appointments are designated as security sensitive positions. The project described is supported by Award Number T32DA031115 from the National Institute on Drug Abuse. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse or the National Institutes of Health.